LOGWX | VISGX | LOGWX / VISGX | |
Total Expense Ratio | 0.59 | 0.19 | 311% |
Annual Report Gross Expense Ratio | 0.59 | 0.19 | 311% |
Fund Existence | 8 years | 27 years | - |
Gain YTD | -0.634 | 2.589 | -24% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.93B | 36.9B | 5% |
Annual Yield % from dividends | 0.20 | 0.43 | 48% |
Returns for 1 year | 8.29 | 12.27 | 68% |
Returns for 3 years | 27.54 | 38.15 | 72% |
Returns for 5 years | 0.39 | 40.06 | 1% |
Returns for 10 years | N/A | 120.87 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ZVNBX | 42.25 | 0.38 | +0.91% |
Zevenbergen Growth Investor | |||
FCDTX | 35.10 | 0.30 | +0.86% |
Fidelity Advisor Stock Selector Sm Cp M | |||
RYSGX | 52.78 | 0.30 | +0.57% |
Rydex S&P SmallCap 600 Pure Growth A | |||
PHLQX | 42.91 | 0.22 | +0.52% |
PGIM Jennison Health Sciences R6 | |||
MSECX | 11.18 | 0.01 | +0.09% |
Morgan Stanley Inst International Eq C |